Skip to main content
. 2019 Sep 17;18:388–399. doi: 10.1016/j.omtn.2019.09.005

Figure 4.

Figure 4

Knockdown of MALAT1 Inhibited GBM Progression and ZHX1 Expression In Vivo

(A) Representative axial MR images and H&E staining of xenograft GBM tumors in normal control, miR-199a inhibitor, and MALAT1-KD groups. (B) Tumor volume in normal control, miR-199a inhibitor, and MALAT1-KD groups. (C) Comparative survival of mice bearing normal control, miR-199a inhibitor, and MALAT1-KD. (D and E) Western blot analysis (D) and densitometric quantification (E) of ZHX1 in tumor tissues collected from nude mice injected with normal control, miR-199a inhibitor, and MALAT1-KD. *p < 0.05.